ID
16165
Description
Phase II Dasatinib Study in Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00546104
Link
https://clinicaltrials.gov/show/NCT00546104
Keywords
Versions (1)
- 7/3/16 7/3/16 -
Uploaded on
July 3, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Advanced Breast Cancer NCT00546104
Eligibility Advanced Breast Cancer NCT00546104
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
pregnant or breast feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Description
dasatinib
Data type
boolean
Alias
- UMLS CUI [1]
- C1455147
Description
bone disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0005940
Description
gastrointestinal bleeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0017181
Description
septicemia, acute hepatitis
Data type
boolean
Alias
- UMLS CUI [1]
- C0036690
- UMLS CUI [2]
- C0267797
Similar models
Eligibility Advanced Breast Cancer NCT00546104
- StudyEvent: Eligibility
C0232805 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C0267797 (UMLS CUI [2])